Creo Medical Group Plc (CREO) Ord GBP0.001
- Add to watchlist
- Create an alert
- This stock can be held in a
31.75p
32.50p
49.00p
£113.06 million
32.50p
31.00p
28.25p
n/a
3.75p (13.04%) Previous:
3.75p
429,995
n/a
10,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue (£m) | 30.80 | 27.20 |
Profit before tax (£m) | (24.50) | (30.90) |
Adjusted EPS (p): | (7.00) | (14.48) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Creo Medical reports year of solid progress
26 June 2024 13:43
-
Creo device used in 'groundbreaking' lung cancer procedure
1 March 2024 14:06
-
Creo Medical FY revenues up double digits
7 February 2024 11:49
-
Holding(s) in Company
29 August 2024 11:05
-
Award of Shares under Share Incentive Plan
1 August 2024 07:00
-
Creo and Intuitive amend collaboration agreement
2 July 2024 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.